NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

遠端患者監護市場預測(2021年∼2026年)

Remote Patient Monitoring Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1013766
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
遠端患者監護市場預測(2021年∼2026年) Remote Patient Monitoring Market - Forecasts from 2021 to 2026
出版日期: 2021年05月10日內容資訊: 英文 104 Pages
簡介

全球遠端患者監護的市場規模在2019年估算為200億2,700萬美元,在2020年∼2026年間預測將以22.94%的年複合成長率推移,到2026年達到850億3,100萬美元。遠程病人監護使用數字技術收集醫療數據和其他各種數據,並將其發送給醫療機構。可以在患者家中收集數據,避免長期護理和住院費用。近年來,在可支配收入增加和老齡化社會導致需求增加的背景下,遠程患者監護市場顯著增長。隨著近年來慢性病的增加,對擴展醫療基礎設施和遠程醫療/遠程患者監護技術的需求越來越大。

本報告提供全球遠端患者監護市場調查,提供市場概要,設備·終端用戶·產業·各地區的市場規模的變化與預測,市場成長的推動要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場成長要素
  • 市場阻礙因素
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 價值鏈分析

第5章 全球遠端患者監護市場分析:各設備

  • 簡介
  • 生理監護器
  • 血糖值螢幕
  • 血壓計
  • 心率監測器
  • 呼吸螢幕
  • 其他

第6章 全球遠端患者監護市場分析:各終端用戶

  • 簡介
  • 醫院·診療所
  • 救護車
  • 居家醫療

第7章 全球遠端患者監護市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 其他
  • 中東·非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 印尼
    • 台灣
    • 泰國
    • 其他

第8章 競爭環境與分析

  • 競爭基準
  • 近幾年的投資和交易趨勢
  • 主要企業的策略

第9章 企業簡介

  • Philips Healthcare
  • Abbott Laboratories
  • GE Healthcare
  • Boston Scientific Corporation
  • Biotronik SE
  • Honeywell International, Inc.
  • Nihon Kohden Corporation
  • OSI Systems, Inc
  • AMC, Inc
  • Qualcomm Life, Inc
目錄

The remote patient monitoring market is expected to reach US$85.031 billion by the end of 2026, increasing from US$20.027 billion in 2019, growing at a CAGR of 22.94% during the forecast period.

Remote patient monitoring makes use of digital technologies to collect medical and various other forms of health data and transmit them to a healthcare provider. The data can be collected at the patient's residence, avoiding the nursing and hospitalization costs. The market for remote patient monitoring witnessed significant growth in recent years owing to a rise in disposable income and increasing demand from an aging population. In the last few years, there has been a growing need to expand the healthcare access infrastructure, cost benefits of telehealth, and remote patient monitoring technology due to the rapidly increasing population and the common occurrence of chronic diseases, globally. According to the Center for Disease Control and Prevention (CDC), chronic diseases account for 90% of the total healthcare costs in the United States annually. By adopting the remote patient monitoring systems, these costs can be reduced significantly which in turn is expected to propel the market growth. Also, by using remote monitoring systems, chronic diseases can be prevented as early warning signs and progress trackers coupled with timely assistance will be provided to the patients which will delay emergency room visits and hospitalizations in the near future. The remote patient monitoring system has several benefits such as a reduction in medical expenditure as the entire hospitalization cost gets eliminated is encouraging more patients to opt for this system rather than the conventional hospitalization method. In addition, the availability of technologically advanced products, increasing investments in telehealth, the support of the Government in various countries, and the rising awareness regarding the benefits of remote patient monitoring are the major factors driving the demand for these systems. Several medical associations worldwide support the remote patient monitoring system owing to the benefits it entails, which is further projected to fuel the market growth. For instance, the American Heart Association (AHA) supports initiatives that increase access to the use of Remote Patient Monitoring (RPM) technologies for better health management. Furthermore, the remote patient monitoring system is simple, convenient, and much easier to use by all age groups, especially by the geriatric population. According to a report by the World Population Ageing, in 2019, there were around 703 million people aged 65 years or over. This number is projected to double to 1.5 billion in 2050. The constant increase in the geriatric population will further support the growth of the remote patient monitoring market during the forecast period.

By end-user, the hospitals and clinic segment is estimated to hold a dominant market share owing to the voluminous number of patients and tests being conducted in them. The home care segment is also projected to grow notably in the years to come. Geographically, North America is expected to grow significantly due to the increase in the occurrence of chronic diseases, demand for wireless and portable systems, the presence of sophisticated reimbursement structures, and a reduction in medical expenditure. The Asia Pacific region is further estimated to witness significant growth over the projected period, attributable to rising healthcare expenditure and an increase in disposable income over the forecast period. The increasing geriatric population in India, China, and Japan are further expected to expand the market during the forecast period.

Growth Factors.

  • Increasing geriatric population

The constantly growing geriatric population is expected to drive the growth of the remote patient monitoring market. According to the World Health Organization, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019, and this number is projected to rise further to 16% in 2050. The increasing number of people in the segment will subsequently increase the demand for remote patient monitoring systems as the number of patients suffering from chronic diseases will increase. The government across the globe will be pressurized to promote remote patient monitoring systems to meet the increasing demand, which in turn is projected to fuel the market growth.

  • Reduction in expenditure

Remote patient monitoring enhances the overall reach and access of healthcare while reducing unnecessary visits to the hospitals for diagnosis, treatment, and admission. The remote patient monitoring also saves a lot of time as the setup is done at one's residence, which eliminates the traveling and waiting time. Furthermore, it helps in considerably reducing expenditure on hospitalization, nursing, traveling, etc. These benefits are expected to attract more patients to shift to remote monitoring systems instead of conventional systems in the next few years.

Restraints.

  • Resistance and Fraud

Many healthcare professionals are resisting the remote patient monitoring system as the dependency of the patients on them will reduce which may affect their professional growth. The healthcare professionals often advise the patients against this system which may hamper the growth of the market. Also, healthcare fraud in telehealth and telemedicine practices can hinder the market growth as issues related to fraudulent reimbursement claims, billing cycle, etc. can be prevalent in the market.

Impact of COVID-19.

The Covid-19 pandemic resulted in a mass shortage of vacant beds in hospitals, worldwide. The patients suffering from chronic illness were advised against visiting hospitals physically for treatment due to the fear of being infected. This trend encouraged hospitals to implement a remote patient monitoring system to keep track of a patient's health and to ensure no patient suffers due to a shortage of healthcare infrastructure. Thus, the pandemic greatly accelerated the growth of the remote patient monitoring market.

Competitive Insights.

Prominent/major key market players in the Remote Patient Monitoring Market include Philips Healthcare, Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Biotronik SE, Honeywell International, Inc., Nihon Kohden Corporation, OSI Systems, Inc, AMC, Inc., and Qualcomm Life, Inc. The players in the Remote Patient Monitoring Market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. For Instance, in 2020, Philips launched the Avalon CL Fetal and Maternal Pod and Patch for remote monitoring in the United States, Europe, Australia, New Zealand, and Singapore to support fetal and maternal monitoring. Also, Koninklijke Philips formed a collaboration with American Telemedicine Association (ATA), to help increase the adoption of telehealth across acute, post-acute, and home care settings. Major market players in the market have been covered along with their relative competitive strategies in this report and the report mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the Remote Patient Monitoring Market.

Segmentation:

  • By Devices
  • Vital Signs Monitor
  • Glucose Monitor
  • Blood Pressure Monitor
  • Heart Rate Monitors
  • Respiratory Monitors
  • Others
  • By End-User
  • Hospitals and Clinics
  • Ambulance
  • Homecare
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Remote Patient Monitoring Market Analysis, By Devices

  • 5.1. Introduction
  • 5.2. Vital Signs Monitor
  • 5.3. Glucose Monitor
  • 5.4. Blood Pressure Monitor
  • 5.5. Heart Rate Monitor
  • 5.6. Respiratory Monitors
  • 5.7. Others

6. Remote Patient Monitoring Market Analysis, By End-User

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Ambulance
  • 6.4. Homecare

7. Remote Patient Monitoring Market Analysis, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. Indonesia
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Others

8. Competitive Intelligence

  • 8.1. Competitive Benchmarking and Analysis
  • 8.2. Recent Investment and Deals
  • 8.3. Strategies of Key Players

9. Company Profiles

  • 9.1. Philips Healthcare
  • 9.2. Abbott Laboratories
  • 9.3. GE Healthcare
  • 9.4. Boston Scientific Corporation
  • 9.5. Biotronik SE
  • 9.6. Honeywell International, Inc.
  • 9.7. Nihon Kohden Corporation
  • 9.8. OSI Systems, Inc
  • 9.9. AMC, Inc
  • 9.10. Qualcomm Life, Inc.